HomeMARKSANS • NSE
add
Marksans Pharma Ltd
Previous close
₹183.44
Day range
₹180.98 - ₹185.50
Year range
₹162.00 - ₹358.70
Market cap
82.93B INR
Avg Volume
1.13M
P/E ratio
23.68
Dividend yield
0.44%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 6.20B | 4.97% |
Operating expense | 2.81B | 27.31% |
Net income | 583.17M | -34.29% |
Net profit margin | 9.41 | -37.39% |
Earnings per share | — | — |
EBITDA | 910.36M | -28.07% |
Effective tax rate | 24.02% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.06B | 0.77% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 24.89B | — |
Shares outstanding | 452.07M | — |
Price to book | 3.37 | — |
Return on assets | — | — |
Return on capital | 6.85% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 583.17M | -34.29% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1992
Website
Employees
1,840
